Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Carcinoma, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Early research (Phase 1)Study completedNCT03368196
What this trial is testing

DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein

Who this might be right for
Adenocarcinoma, GastricNeoplasm, Breast
Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company 12
Testing effectiveness (Phase 2)Looking for participantsNCT06799065
What this trial is testing

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

Who this might be right for
Advanced Solid TumorsBreast Cancer RecurrentOvarian Cancer+4 more
Accent Therapeutics 218
Testing effectiveness (Phase 2)Looking for participantsNCT06998407
What this trial is testing

ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid Tumors

Who this might be right for
HR+/HER2- Breast CancerHR+, HER2-, Advanced Breast Cancer
Avenzo Therapeutics, Inc. 380
Testing effectiveness (Phase 2)Study completedNCT01325428
What this trial is testing

Afatinib (BIBW2992) in HER2 (Human Epidermal Growth Factor Receptor 2)-Overexpressing Inflammatory Breast Cancer

Who this might be right for
Breast Neoplasms
Boehringer Ingelheim 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT06247995
What this trial is testing

A Phase I/II, Dose Finding and Optimization Study of [177Lu]Lu-NeoB in Combination With Capecitabine in Patients With GRPR+, ER+, HER2- Metastatic Breast Cancer After Progression on Previous Endocrine Therapy in Combination With a CDK4/6 Inhibitor.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 20
Large-scale testing (Phase 3)UnknownNCT01479036
What this trial is testing

Trial of Neoadjuvant Endostar, Docetaxel and Epirubicin for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Xijing Hospital 800
Testing effectiveness (Phase 2)Ended earlyNCT01339000
What this trial is testing

Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy

Who this might be right for
Breast CancerColon CancerBladder Cancer
National Cancer Institute (NCI) 1